Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Avra
AddedFeb 18, 2024
UpdatedJun 18, 2026
Avra

Avra

Seed

Newregen Inc: A global biotech firm specializing in stem cell treatments and anti-aging solutions.

HQ
Palo Alto, CA, US
Founded
2010
Overview
Compare
Fundraising
Employees
News

Avra, operating as Newregen Inc, is a global biotech firm specializing in stem cell treatments and anti-aging solutions. The company offers a range of services including stem cell orthopedic treatments, joint restoration, non-surgical hair restoration, and aesthetic treatments. Their mission is to provide innovative, non-invasive medical solutions to improve health and longevity for customers worldwide.

Newregen Inc has made significant strides in the biotech industry, particularly in the field of regenerative medicine. Their pioneering stem cell therapies have attracted a global clientele, enhancing the quality of life for many individuals. The company's innovative approach and commitment to cutting-edge research have positioned it as a leader in the market.

Avra - Similar Companies

AVITA Medical logo

AVITA Medical

avitamedical.com

AgeX Therapeutics logo

AgeX Therapeutics

Forever Labs logo

Forever Labs

foreverlabs.com

BioRegenx logo

BioRegenx

bioregenx.com

Stemgenics logo

Stemgenics

stemgenics.com

AVM Biotechnology logo

AVM Biotechnology

avmbiotech.com

Cellebration Life Sciences logo

Cellebration Life Sciences

Longeveron logo

Longeveron

longeveron.com

Antria logo

Antria

antria.org

Regennova logo

Regennova

regennova.com

InGeneron logo

InGeneron

ingeneron.com

Stemson Therapeutics logo

Stemson Therapeutics

stemsontx.com

Stemtech logo

Stemtech

stemtech.com

iReprogram logo

iReprogram

ireprogram.com

Avalon GloboCare logo

Avalon GloboCare

Avra - Quick Facts

Who are Avra's competitors?

Companies similar to Avra include AVITA Medical, AgeX Therapeutics, Forever Labs and BioRegenx.

When was Avra founded?

Avra was founded in 2010.

Where is Avra's headquarters located?

Avra's headquarters is located in Palo Alto, CA, US.

When was Avra's last funding round?

Avra's most recent funding round was for $150k (USD) in December 2014.

How much has Avra raised to-date?

As of Dec 10, 2014, Avra has raised a total of $150k (USD).

How many employees does Avra have?

Avra has 6 employees as of Feb 4, 2024.

Avra - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Anti-Aging
  • Stem Cell Treatments
Tags
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software